Shopping Cart
- Remove All
Your shopping cart is currently empty
ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | Inquiry | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | |
| 100 mg | Inquiry | 10-14 weeks |
| Description | ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment. |
| Molecular Weight | 1461.66 |
| Formula | C71H100N18O16 |
| Cas No. | 2040964-58-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.